Uncover opportunities in a high-growth market

Daily Analysis

Our analysts monitor developments across the global healthcare industry including expenditure, government health budgets, digital health policies and company news, with specialist insight into the latest developments in emerging markets.

Annual Reports

Data-led market overviews for 108 countries including 10-year forecasts for public and private healthcare expenditure, and analysis of systems, stakeholders, regulations, resources, activity, and advancements in digital health.

Data and Forecasts

Up to 25-year historical data and 10-year forecasts for 200+ indicators across 108 markets, including hospitals, physicians, nurses, inpatient admissions, outpatient visits, surgical procedures and demographics.

Datapacks

Exportable Excel Datapacks for 108 markets can be accessed directly from the annual reports and include all the latest sub-national and country-specific healthcare data and forecasts for each market.

Get deep insights into healthcare trends

Healthcare Key Themes For 2024

In 2024, healthcare topics will have reduced prominence in elections and political events compared to recent years, due to the emergence of more urgent issues and a decrease in challenges related to Covid-19.

Latest Healthcare Indicators

From Algeria to Zimbabwe, our extensive healthcare dataset provides over 200 key indicators for more than 100 markets including government healthcare expenditure and private healthcare expenditure, healthcare facilities and personnel, medical tourism, and health insurance.

Connect with our thinking

We integrate political, macroeconomic, and cross-industry expertise into our healthcare industry analysis, allowing our customers to benefit from understanding how each factor impacts on the other in their chosen markets.

Latest Insights

Highlight / Latin America, Argentina /

Argentine Drug Sales Under Pressure Amid Escalating Prices

Events

Long Reads

Asia Pacific Pharma & Healthcare Insight (February 2024)

On January 13 2023, AstraZeneca unveiled its strategic investment plan, committing CNY190.0mn (USD26.7mn) towards the establishment of a new manufacturing line within the Taizhou Medical Hi-Tech Zone in Mainland China.

BMI Global Macro & Industry Key Themes 2024

In 2024, the global economy will continue to face headwinds in the form of slower growth as the lagged effects of policy tightening in 2022 and 2023 start taking effect.

Cancer Drug News (September 2023)

The latest positive clinical trial readouts from Bristol Myers Squibb (BMS) further support the broader use of Opdivo (nivolumab) in lung cancer treatment. September 2023 edition.

Middle East & Africa Pharma & Healthcare Insight (September 2023)

The Egyptian Drug Authority has celebrated the first export of locally manufactured pharmaceuticals to Zimbabwe, which comes as part of Egypt's wider efforts to boost its local manufacturing capacity and engage in further trade agreements with countries in the Middle East and North Africa region. September 2023 edition.

Diagnostics Focus (September 2023)

The rapid decline in COVID-19 testing-related sales continues to pose headwinds for diagnostic companies, which is reflected in Q223 revenues and FY23 guidance. September 2023 edition.

Middle East and Africa Pharma & Healthcare Insight (July 2023)

Egypt is currently implementing a new universal health insurance (UHI) scheme which aims to tackle the country’s high out-of-pocket (OOP) costs and the fragmented nature of pooled funds. July 2021 Edition. gettyimages-1128676528.jpg

Medical Industry Week (July 2023)

Roche continues to emerge as a dominant player in cerebrospinal fluid (CSF) and blood-based diagnostic tests for Alzheimer’s disease (AD). In June 2023, Roche received FDA clearance of its Elecsys beta-amyloid (1-42) CSF II (Abeta42) and Elecsys Total-Tau CSF assays (tTau) to help clinicians spot early signs of AD. gettyimages-1041685750_640.jpg

Presenting BMI’s Key Megatrends

On 21st June 2023 we launched the 4th edition of Towards 2050: Megatrends in Industry, Politics and The Global Economy at an exclusive event in London, where BMI’s senior analysts explored some of the key themes from the report in more detail.

RELATED PRODUCTS

You may also be interested in:

BMI Advisory

Tailored research and risk management analytics, to guide your critical business decisions.

 

BMI Country Risk

Expert analysis of the political and economic risks that could impact your growth strategies in more than 200 markets.

BMI Operational Risk

Detailed analysis of business environment risks and comparable data evaluating the ease of doing business in world markets.

Fitch Ratings Credit Research

Quickly and thoroughly evaluate the creditworthiness of a company, country, or security with timely, independent credit research from Fitch Ratings.

Fitch Credit Ratings Data

Make better investment and credit risk decisions with Fitch Ratings multi award-winning credit ratings data.

Gauge demand for healthcare products and services

Request a demonstration of Healthcare Industry Research to discover how we can help you understand opportunities and risks across more than 100 markets.

Once you complete the form, one of our specialists will be in touch to discuss how our data and research can be seamlessly delivered to match your needs.

Thank you for your request. One of our specialists will be in touch shortly.

If you need immediate assistance, please contact our nearest office.

Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.